Oral News and Research

RSS

One year and no recorded polio cases in India

The World Health Organization (WHO) reports that India has recorded no cases of polio for one full year - a significant benchmark for the South Asian nation and an encouraging development for health professionals fighting to eradicate the stubborn disease worldwide.

15 Jan 2012

Supreme Court considers medical leave lawsuit

The high court heard oral arguments Wednesday in the case that will determine how the federal Family and Medical Leave Act applies to state government workers.

13 Jan 2012

WHO to convene meeting on yaws eradication efforts based on study of oral treatment

"Findings that a one-time oral treatment to cure yaws, a neglected tropical disease, is as effective as the currently recommended penicillin injection have prompted the World Health Organization (WHO) to convene a meeting on how the disease may be wiped out," IRIN reports.

13 Jan 2012

International health groups ally to fight cholera in Haiti; Officials emphasize need for sanitation infrastructure

"Unless steps are taken to eliminate cholera from Haiti and the neighboring Dominican Republic, the disease will likely resurge and could even spread to other parts of the Caribbean, international health officials said Wednesday," CQ HealthBeat reports.

13 Jan 2012

UofL faculty and students make economic impact of $5.7M in four regions of Kentucky

During 2010-2011, University of Louisville Health Sciences Center faculty and students made an economic impact of more than $5.7 million in the four regions of Kentucky served by UofL Area Health Education Centers.

12 Jan 2012

USPTO issues patent to Unigene's peptide-based therapeutics for obesity

Unigene Laboratories, Inc., a leader in the design, delivery, manufacture and development of peptide-based therapeutics, today announced that it had been granted U.S. Patent No. 8,076,291 from the United States Patent and Trademark Office.

11 Jan 2012

Oramed files provisional patent application with USPTO for combination diabetes therapy

Oramed Pharmaceuticals Inc., a developer of oral drug delivery systems, announced today that it has filed a provisional patent application with the United States Patent and Trademark Office for a combination therapy of its lead compound, ORMD-0801 in combination with its oral exenatide formulation, ORMD-0901. There is no such approved combination product available on the market today.

11 Jan 2012

Significant number of young women fail to recognize recent weight gain

Despite popular belief about women's weight concerns, young women commonly fail to recognize recent gain of as many as 11 pounds - putting them at risk for cardiovascular disease and other obesity-related conditions.

11 Jan 2012

Positive interim data from Idenix IDX184 12-week phase IIb trial on HCV

Idenix Pharmaceuticals, Inc., a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced interim data from a 12-week phase IIb clinical trial of IDX184, the Company's lead product candidate for the treatment of hepatitis C virus (HCV) infection.

9 Jan 2012

Presidio completes PPI-668 Phase 1a study on hepatitis C

Presidio Pharmaceuticals, Inc. announced today the successful completion of a Phase 1a dose-ranging assessment of PPI-668, a potent, pan-genotypic second-generation hepatitis C virus (HCV) NS5A inhibitor, in healthy volunteers and subsequent advancement to a Phase 1b assessment of the dose-related efficacy in hepatitis C patients.

9 Jan 2012

Pfizer, SFJ to conduct axitinib Phase 3 trial in renal cell carcinoma

SFJ Pharma Ltd. II announced today that it has entered into a collaborative development agreement with Pfizer Inc. to conduct a Phase 3 clinical trial in Asia of Pfizer's investigational agent axitinib for the adjuvant treatment of patients at high risk of recurrent renal cell carcinoma (RCC) following nephrectomy.

9 Jan 2012

Bristol-Myers Squibb signs definitive agreement to acquire Inhibitex

Bristol-Myers Squibb Company and Inhibitex, Inc. announced today that the companies have signed a definitive agreement under which Bristol-Myers Squibb will acquire Inhibitex for $26.00 per share in cash pursuant to a cash tender offer and second step merger.

8 Jan 2012

OCF to offer free oral cancer screenings in April 2012

Did you know that the fastest growing segment of the oral cancer community is young, healthy non-smokers? It's shocking but true. Exposure to the HPV-16 virus, the most common sexually transmitted infection, is now the leading cause of oral cancers in the U.S. There is little that can be done to stop this virus from spreading. Our only hope to save lives is through increased professional involvement and public awareness to generate early discovery of the disease process.

7 Jan 2012

Cardinal Health launches infusion room management tool for community rheumatologists

Cardinal Health Specialty Solutions today launched InfusaTrack, a Web-based infusion room management tool that makes it easier for community rheumatology practices to offer in-office infusion therapy services to patients.

7 Jan 2012

ACLJ urges U.S. Supreme Court to declare flawed health care law unconstitutional

On behalf of nearly 120 members of Congress and more than 100,000 Americans, the American Center for Law and Justice (ACLJ) today urged the U.S. Supreme Court to conclude that a key provision of ObamaCare - the individual mandate - cannot be severed from the health care law and urged the high court to declare the entire law unconstitutional.

7 Jan 2012

Smokeless tobacco products in India associated with increased risk of oral cancer

The 2nd International Conference on the Frontiers in Prevention, Diagnosis & Therapy of Cancer was held on 7th Jan. 2012 at Allahabad, India and looked at the relationship of oral cancer with tobacco habits. Various innovations in oral cancer diagnosis, therapy and tobacco usage were discussed by experts from around the world.

7 Jan 2012

First Bright Now! Dental office opens in Orlando

Smile Brands Inc., the nation's leading provider of business support services to dental groups in the United States, today announced the grand opening of its first Bright Now! Dental office of the new year, in Orlando, FL. This new office in Orlando Square will be the fifth Bright Now! Dental office in the Orlando area. The first Bright Now! Dental office in the Orlando market opened in May, 2011 in Casselberry, FL.

7 Jan 2012

Positive topline results from Civitas' CVT-301 Phase 1 trial on PD

Civitas Therapeutics, Inc., a privately-held pharmaceutical company developing transformative therapeutics using the ARCUS(TM) respiratory delivery platform, announced today positive topline results from a Phase 1 clinical trial for CVT-301, an inhaled formulation of levodopa (L-dopa) for the rapid relief from motor fluctuations associated with Parkinson's disease.

7 Jan 2012

Celtaxsys announces acquisition of CTX-4430 from Estrellita

Celtaxsys, Inc. a privately held biotechnology company, announced today that it has acquired CTX-4430 (formerly EP-501), a clinical stage drug candidate that inhibits the pro-inflammatory enzyme Leukotriene A4 Hydrolase (LTA4H), from Estrellita Pharmaceuticals, Inc.

6 Jan 2012

SonoPhoto Dynamic Therapy shows promise against squamous cell carcinoma

George Miller developed an ulcer on his bottom lip that began to bleed. His doctor sent cell scrapings to a pathologist, and diagnosed Miller with squamous cell carcinoma (SCC). According to TMD Limited, a medical tourism company, squamous cell carcinoma is the 2nd most common cancer in humans and other animals.

6 Jan 2012

Oral News and Research

One year and no recorded polio cases in India

Supreme Court considers medical leave lawsuit

WHO to convene meeting on yaws eradication efforts based on study of oral treatment

International health groups ally to fight cholera in Haiti; Officials emphasize need for sanitation infrastructure

UofL faculty and students make economic impact of $5.7M in four regions of Kentucky

USPTO issues patent to Unigene's peptide-based therapeutics for obesity

Oramed files provisional patent application with USPTO for combination diabetes therapy

Significant number of young women fail to recognize recent weight gain

Positive interim data from Idenix IDX184 12-week phase IIb trial on HCV

Presidio completes PPI-668 Phase 1a study on hepatitis C

Pfizer, SFJ to conduct axitinib Phase 3 trial in renal cell carcinoma

Bristol-Myers Squibb signs definitive agreement to acquire Inhibitex

OCF to offer free oral cancer screenings in April 2012

Cardinal Health launches infusion room management tool for community rheumatologists

ACLJ urges U.S. Supreme Court to declare flawed health care law unconstitutional

Smokeless tobacco products in India associated with increased risk of oral cancer

First Bright Now! Dental office opens in Orlando

Positive topline results from Civitas' CVT-301 Phase 1 trial on PD

Celtaxsys announces acquisition of CTX-4430 from Estrellita

SonoPhoto Dynamic Therapy shows promise against squamous cell carcinoma

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News